Maria Karasarides PhD

Maria Karasarides is Vice President and Head of Early Assets & Biomarkers at Bristol Myers Squibb. She completed her PhD in Biology, Biochemistry, and Cancer Biology. Her clinical interests are Oncology, Medical Affairs, Pharmaceutical Industry, Biopharmaceuticals, and Drug Discovery.